United States Diagnostic Imaging Services Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

United States Diagnostic Imaging Services Market Trends and Insights

Aging Chronic-Disease Imaging Volumes

The US diagnostic imaging services market has a durable demand floor because chronic disease prevalence remains high in adults age 45 and older, and those conditions often require repeated imaging across diagnosis, monitoring, and follow-up care^{[1]Xun Wang and Lindsey I. Black, “Prevalence of Selected Chronic Conditions Among Adults Age 45 and Older, by Age and Urbanization Level, United States, 2024,” NCHS Data Brief, cdc.gov}. Heart disease, cancer, COPD, and stroke all become more common with age, which means imaging demand rises not only because the population is aging, but also because older patients tend to move through several imaging pathways at the same time. This pattern supports study growth across CT, MRI, nuclear imaging, ultrasound, and X-ray, because multimorbidity increases the number of scans attached to a single episode of care. The US diagnostic imaging services market therefore benefits from a patient mix where recurring surveillance matters as much as first diagnosis, especially in oncology, cardiology, and neurology. That demand base is difficult to displace because it is linked to long-cycle care needs rather than discretionary procedure use.

Screening-Led Early Diagnosis Demand

The US diagnostic imaging services market is also benefiting from broader screening pathways that enlarge the pool of patients entering imaging earlier in the care journey. The 2024 USPSTF breast cancer screening update lowered the recommended start age to 40 for biennial mammography, which should support a larger screening population over time. A 2024 JAMA Network Open study also showed that broader age-based lung cancer screening could prevent 26,124 deaths annually and be 6 times more cost-effective than current screening approaches, which points to further procedure upside if eligibility expands in future policy cycles. These changes favor operators with strong outpatient screening capacity, because mammography, CT, and follow-on imaging referrals tend to build around dense, convenient access points. Solis Mammography’s October 2025 acquisition of the St. Louis Breast Center shows how specialized screening providers are expanding into additional metropolitan areas to capture that volume growth.

AI-Enabled Workflow and Scan Productivity

AI deployment is shifting from a pilot activity into operating infrastructure across the US diagnostic imaging services market. A 2025 JAMA Network Open study found that a generative AI system used across Northwestern Medicine improved documentation efficiency by 15.5%, with some radiologists recording gains of up to 40%, while peer review found no decline in text quality or clinical accuracy. A separate 2025 study in npj Digital Medicine reported that a keyword-based AI reporting approach reduced radiology resident reporting time by a median of 28%. RadNet stated that more than 70% of its studies could run through clinical AI by the end of 2026, and the company reported a 35.2% year-on-year increase in PET/CT volumes in Q1 2026, which shows how workflow software is being used to support higher-acuity growth without matching headcount growth one for one. Microsoft’s Dragon Copilot launch for radiologists at RSNA 2025 adds another signal that large software vendors now view radiology workflow as a recurring platform category rather than a temporary feature set.

Virtual Direct Supervision for Contrast Imaging

Regulatory change is opening a practical access lever for the US diagnostic imaging services market, especially outside major metro areas. Reed Smith noted that CMS made virtual direct supervision permanent from January 1, 2026 for Level 2 diagnostic tests, including CT and MRI with contrast, through real-time two-way audio and video capability in office and hospital outpatient settings. This matters because independent diagnostic testing facilities and freestanding centers had faced a harder path to contrast study retention when physical physician presence was required. The rule should support better revenue mix at rural and semi-urban sites by allowing them to keep cases that might otherwise have been redirected to hospital outpatient departments. The effect is likely to be strongest in geographies where imaging demand exists but staffing density remains thin. Implementation will still vary because state boards and professional bodies can impose added requirements, so operators with stronger compliance infrastructure are better placed to capture the benefit.

Radiologist And Technologist Shortages

Workforce shortage remains one of the clearest structural constraints on the US diagnostic imaging services market. Research published in the American Journal of Neuroradiology in April 2025 reported 31,825 ACR Career Center listings against 10,180 anticipated diagnostic radiology residency graduates through the NRMP period reviewed, which implies a large mismatch between demand and training output^{[2]American Journal of Neuroradiology, “In Plain Sight, a Radiology Workforce Crisis in the Making,” American Journal of Neuroradiology, ajnr.org}. The pressure is most visible in advanced imaging and subspecialty reads, where delays can reduce throughput, stretch turnaround times, and weaken referral retention. This is one reason the US diagnostic imaging services market is leaning more heavily on automation, centralized reading platforms, and network models that can move studies across a broader clinician base. The shortage also tilts bargaining power toward larger organizations that can offer better compensation, deeper support teams, and more flexible reading arrangements.

Reimbursement And Margin Pressure

Margin pressure remains a steady restraint on the US diagnostic imaging services market even as procedure demand rises. CMS set the CY 2025 Medicare Physician Fee Schedule conversion factor at USD 32.35 per RVU, down 2.83% from CY 2024, and interventional radiology faced an even steeper 4.83% reduction. KFF also described the November 2025 move toward site-neutral payment reform as modest but directionally important, which means reimbursement alignment pressure could continue to spread across hospital outpatient economics. Smaller independent groups are more exposed because labor costs have been rising at the same time that Medicare-linked rates have been moving lower. This gap between rising volume and tighter unit economics is supporting consolidation, especially where larger networks can use AI, preferred contracts, and centralized operations to protect margins.

Segment Analysis

By Modality: X-Ray Holds The Largest Revenue Base While CT Advances Fastest

X-ray accounted for 28.31% of revenue in 2025, which kept it as the largest modality in the US diagnostic imaging services market because it remains essential across emergency care, orthopedics, and chest evaluation. The segment’s scale rests on procedure breadth rather than on high ticket pricing, which means revenue share remains strong even though CT and MRI often generate more value per exam. This wide clinical footprint gives X-ray a stabilizing role in the US diagnostic imaging services market because it supports both acute and routine imaging demand across hospitals and outpatient sites. AI adoption is also beginning to improve throughput in this modality, especially where report generation and documentation can be standardized. SimonMed Imaging’s December 2025 partnership with Lunit to deploy multimodal foundation models for chest X-ray report generation shows that even high-volume, lower-ticket categories are becoming part of the next operating model.

Computed Tomography is the fastest-growing modality, with the US diagnostic imaging services market size for CT projected to expand at a 6.38% CAGR through 2031. CT is gaining share of incremental study growth because it sits at the center of lung screening, cardiovascular imaging, trauma evaluation, and many oncology pathways. RadNet reported a 17.7% year-on-year increase in CT procedural volumes in Q1 2026, while same-center CT volumes rose 4.7%, which indicates that demand is growing both organically and through network expansion. MRI is also expanding on the back of neurological, musculoskeletal, and cardiac use, and RadNet stated that same-center MRI volume rose 10.0% in Q1 2026. Ultrasound and mammography remain important growth supports because they benefit from portability, lower patient friction, and stronger preventive screening use, while SimonMed’s January 2025 partnership with Siemens Healthineers for liver disease screening reflects continued modality-specific investment in ultrasound workflows.

By Application: Oncology Leads Revenue While Neurology And Spine Grow Fastest

Oncology represented 33.24% of revenue in 2025, giving it the largest application position in the US diagnostic imaging services market. That leadership reflects the longitudinal structure of cancer care, where patients often move through staging, restaging, treatment response monitoring, and recurrence surveillance across several modalities. The segment also benefits from the way screening expansion feeds downstream advanced imaging, especially when suspicious findings generate follow-up CT, MRI, ultrasound, or nuclear imaging. Oncology volumes therefore support both baseline utilization and higher-value cross-sectional procedures across provider networks. Radiology Partners’ October 2025 launch of Mammo Enhance Heart also shows how screening infrastructure can be used to widen clinical value capture from existing imaging touchpoints.

Neurology and Spine is the fastest-growing application, with the US diagnostic imaging services market size for this segment expected to rise at a 7.52% CAGR through 2031. MRI demand is a major driver because stroke workup, multiple sclerosis follow-up, degenerative spine disease, and cognitive decline assessment all depend on repeated imaging over time. Cardiology imaging remains an important adjacent volume stream, but the ASNC-reported Tc-99m pyrophosphate shortage in early 2025 showed how nuclear cardiology can be disrupted by supply issues outside provider control. Orthopedics and musculoskeletal imaging continue to provide high-frequency demand because aging patients and outpatient joint procedures support recurring diagnostic needs. Women’s Health and Obstetrics also stand to gain from expanded screening and supplemental follow-up pathways, while General Imaging remains a dependable base because emergency departments and primary care referrals continue to generate broad study volume.

By Site Of Care: Hospitals Retain Scale While Freestanding Centers Capture Incremental Growth

Hospital-based imaging departments held 44.52% of the US diagnostic imaging services market share in 2025, which kept them in the lead because they control emergency, inpatient, and high-acuity referral streams. That position remains difficult to dislodge because hospitals manage many of the care settings where imaging is tied directly to urgent decision making and downstream treatment coordination. The US diagnostic imaging services market still depends heavily on these departments for complex and time-sensitive imaging pathways, even as more non-acute volumes move outward. Hospital systems are also adapting by building satellite access points and partnership structures rather than relying only on centralized campus-based imaging. HCA-backed expansion in Florida and Solis Mammography’s continued center rollout in Texas both illustrate how hospital-linked or referral-linked outpatient capacity is being added in fast-growth areas.

Freestanding Imaging Centers are the fastest-growing site of care, with a 6.25% CAGR projected through 2031. Their momentum comes from convenience, lower-cost positioning, and their ability to scale scheduling and equipment use more efficiently in many outpatient settings. Lumexa Imaging shows the model at scale, as the company completed its IPO in December 2025, operated more than 190 centers across 13 states by May 2026, and stated that MRI and CT generated 52% of consolidated revenue in 2025. Community diagnostic centers and polyclinic hubs are also gaining relevance because they can serve suburban and semi-urban populations with broader specialty access. Mobile imaging units continue to fill access gaps in rural and institutional settings, but their expansion remains limited by fleet capacity and reading coverage rather than by a lack of demand.

By Delivery Model: Owned Networks Lead Revenue While Teleradiology-Enabled Models Scale Fastest

Owned and Operated Networks retained 45.62% of revenue in 2025, which reflected the capital intensity and operating leverage built into the US diagnostic imaging services industry. Larger owned networks can centralize purchasing, spread technology costs, negotiate broader contracts, and deploy workflow tools across multiple centers, which gives them advantages in both growth and margin defense. This operating model is especially well suited to the US diagnostic imaging services market because high fixed assets and staffing pressure make density and utilization important profit drivers. RadNet’s Q1 2026 revenue reached USD 575.6 million, up 22.1% year on year, while Adjusted EBITDA rose 36.3% to USD 63.3 million, which supports the view that scale continues to improve financial resilience in network-based imaging. Hospital joint ventures are also becoming more common, and RadNet’s April 2026 arrangement with Trinity Health’s Saint Alphonsus Health System shows how AI deployment is increasingly part of the partnership case rather than an optional add-on.

Teleradiology-enabled Networks are the fastest-growing delivery model, with a projected CAGR of 8.25% through 2031. Their growth is tied to staffing shortages, the need for round-the-clock read capacity, and the January 2026 permanence of virtual direct supervision for relevant diagnostic tests. This widens the addressable opportunity because smaller imaging sites can retain more advanced studies while still using distributed physician oversight. Managed services and outsourcing contracts also remain important where health systems want clinical continuity but prefer not to run all imaging operations directly. Radiology Partners’ April 2025 agreement to support the transition of approximately 95 client sites and onboard up to 400 radiologists from Envision Healthcare’s exiting radiology division illustrates how outsourcing can become a consolidation path for large service platforms.

By Payor: Commercial Plans Hold The Largest Revenue Base While Medicare Expands Fastest

Commercial and Employer-sponsored Plans contributed 48.84% of revenue in 2025, which made them the largest payor category in the US diagnostic imaging services market. Higher reimbursement levels relative to government programs remain the main reason this segment leads revenue, even though utilization growth is not always highest in commercially insured populations. Administrative friction has historically weighed on this category, especially for advanced imaging, but reform efforts are beginning to target that burden directly. HHS and CMS announced in June 2025 that insurers covering nearly 80% of Americans committed to reduce prior authorization volumes and improve related processes, with demonstrated results targeted by January 2026^{[3]U.S. Department of Health and Human Services, “HHS Secretary Kennedy, CMS Administrator Oz Secure Industry Pledge to Fix Broken Prior Authorization System,” HHS, hhs.gov}. A more standardized electronic prior authorization pathway should particularly help high-volume outpatient operators, because fewer approval delays translate directly into better scanner utilization and lower scheduling waste.

Medicare is the fastest-growing payor segment, with the US diagnostic imaging services market size for this category projected to increase at a 6.61% CAGR through 2031. KFF reported that Medicare Advantage enrollment reached 35 million beneficiaries in 2026, up from 34 million in 2025, which confirms the continued rise in the elderly insured population most likely to use imaging frequently. The same KFF analysis also noted 67% growth in Chronic Special Needs Plan enrollment from 2024 to 2025, which indicates stronger concentration of high-acuity patients in managed products. Self-pay imaging remains smaller, but it is receiving some support from cash-pay transparency and direct-to-consumer screening offers at freestanding sites. Medicaid, TRICARE, and workers’ compensation continue to provide stable baseline volume, though they do not currently represent the same growth engine as Medicare in the US diagnostic imaging services industry.

Geography Analysis

The United States functions as a multi-speed geography for the US diagnostic imaging services market, and the fastest expansion is occurring across the Sunbelt because population inflows, outpatient buildout, and older patient concentration all support stronger imaging demand. Texas, Florida, Arizona, and the broader Southeast continue to stand out because these markets combine population growth with a site-of-care mix that is favorable to freestanding and hybrid outpatient expansion. HCA-backed investment of USD 134.5 million in Lee County, Florida and Solis Mammography’s continued Houston-area expansion show how providers are building local density in areas where screening, elective care, and retiree-driven demand continue to rise. RadNet also stated that it was operating 14 centers in the Houston metropolitan area in early 2026 after doubling its footprint since entering the market in 2024, which underscores how quickly large operators are trying to build network density in high-growth Sunbelt corridors.

The Northeast and Mid-Atlantic remain the deepest hospital-based imaging corridor in the country, with strong academic medical center presence and dense urban referral networks supporting advanced modality use. New York, New Jersey, Maryland, Pennsylvania, and Massachusetts continue to offer strong volume depth, but they also face heavier workforce strain because high-acuity imaging demand and subspecialty reading needs remain difficult to staff consistently. RadNet’s established positions in California, New York, New Jersey, and Maryland keep it well placed in these dense referral markets, where access to radiologists and advanced AI tools can be a more important differentiator than simple site count. At the same time, the Midwest is becoming a clearer expansion frontier for the US diagnostic imaging services market because it has historically had less outpatient chain penetration than coastal metros. RadNet’s February 2026 acquisition of Northwest Radiology Network’s six Indianapolis-area centers marked its entry into Indiana and added projected annualized revenue of USD 18 million, which highlights how aggregators are now moving into underpenetrated regional hubs.

Rural markets across the Mountain West and the rural South remain the most underserved parts of the US diagnostic imaging services market, largely because radiologist supply and on-site supervision coverage are thinner than in major metro areas. Workforce variation remains wide, with published 2025 data showing state-level radiologist density ranging from 9 to 25 per 100,000 people, and that gap directly affects access, turnaround times, and the economic viability of advanced imaging outside urban cores. The permanent virtual supervision framework from January 2026 should improve the ability of rural and semi-urban centers to retain contrast procedures instead of referring them outward. That change does not eliminate the underlying staffing gap, but it does improve access economics in geographies where demand exists and the traditional supervision model had been a practical barrier.